Oxford University is the NIAID of the UK–as far as deliberate prevention of effective treatment for Covid goes. Think HCQ poisonings. The two principal investigators fo the Recovery trial (Peter Horby and Martin Landray) are Oxford professors, who dosed people with sufficient HCQ that more patients died in the treatment arm than in the placebo…
From the Aug 1, 2009 Lancet online: Last week, Australia and the USA announced that they would begin trials of an H1N1 vaccine. Vaccination against H1N1 will be an important development in controlling the impact of the pandemic. However, several thorny issues exist around vaccine manufacture and approval. All countries will require the vaccine but…
Jim Binns, chairman of VA’s Research Advisory Committee on GW Veterans’ Illnesses since its inception, authored a detailed memo, with supporting documents, to show how Congress’ statutory charge to the IOM was changed to exclude animal studies and raise the bar for granting presumptive disabilities to ill Gulf War veterans. Jim deserves enormous thanks for…
FDA gave the booster (3d dose) for elementary school children its blessing today. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-vaccine-booster-dose “On Jan. 3, the FDA authorized the use of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for administration to individuals 12 through 15 years of age after completion of primary vaccination with the Pfizer-BioNTech COVID-19 Vaccine. Today’s action…
Including the misdirection, sloppiness and impaired memory of Dr. Faust, the part-time ER doctor and pundit/ expert witness The fifth day of my board hearing was May 30, 7.5 months after it began and 16.5 months since I was suspended for charges that the board dropped prior to litigation. No one can remember the details…
David Brown, M.D., described the most recent Institute of Medicine report on Gulf War Illnesses this week. Brown tried to deny the existence of the illness back in 2006, with reporting that was either uninformed or misleading. Here’s what he wrote in 2006: As recently as September, a panel of the National Academy of Science’s Institute…
Comments are closed.
So far the Morpholino oligos have not been fast tracked as far as I know; there is no funding for their further development. More citations describing their development and clinical testing are here: http://www.gene-tools.com/content/citations-morpholino-work-ebola-or-marburg-filovirus